Gilbert Lynn Marks An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

Gilbert Lynn Marks is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 63,749 shares of ANTX, which is worth approximately $72,673. The most recent transaction as insider was on Oct 10, 2025, when has been sold 10,367 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.7K
19.42% 3M change
n/a 12M change
Total Value Held $72,673

Gilbert Lynn Marks Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 10 2025
BUY
Grant, award, or other acquisition
-
10,367 Added 13.99%
63,749 Common Stock
Jul 10 2025
BUY
Grant, award, or other acquisition
-
11,875 Added 18.2%
53,382 Common Stock
Apr 10 2025
BUY
Grant, award, or other acquisition
-
9,705 Added 18.95%
41,507 Common Stock
Dec 19 2024
BUY
Grant, award, or other acquisition
-
8,972 Added 22.0%
31,802 Common Stock
GLM

Gilbert Lynn Marks

Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX